LCD L36021: MolDX: Molecular Diagnostic Tests (MDT) — CGS
Policy LCD-L36021 · Clinical Laboratory
New MolDX policy effective in 2025 may alter billing processes.
Code intelligence
0031U reimbursement alerts
Policy changes, MAC LCD updates, and CMS guidance matched to code 0031U.
Elevated code riskDenied? See the governing policy
Signal breakdown
7 shown · 7 total in platform
Risk: Elevated
0
Critical
0%
4
High
57%
3
Routine
43%
0
Low
0%
New this month
—
alerts added in last 30 days
Effective soon
—
no upcoming deadlines
High
LCD L36256: MolDX: Molecular Diagnostic Tests (MDT) — Noridian
Policy LCD-L36256 · Clinical Laboratory
New molecular diagnostics policy may impact billing processes.
LCD L35160: MolDX: Molecular Diagnostic Tests (MDT) — Noridian
Policy LCD-L35160 · Clinical Laboratory
New MolDX guidelines may alter MDT billing processes.
LCD L38351: MolDX: Repeat Germline Testing — Noridian
Policy LCD-L38351 · Oncology
New guidelines for repeat germline testing could impact reimbursements.
Proposed LCD DL40246: MolDX: Biomarker Testing for Risk Stratification in DCIS — CGS
Policy LCD-DL40246 · Oncology
New LCD could enhance coverage for DCIS biomarker tests.
LCD L38288: MolDX: Repeat Germline Testing — CGS
Policy LCD-L38288 · Oncology
New LCD may impact repeat germline testing reimbursements.
LCD L38353: MolDX: Repeat Germline Testing — Noridian
Policy LCD-L38353 · Clinical Laboratory
New LCD on germline testing impacts billing practices.
Audit documentation
Building an audit file that includes 0031U?
The Tripwire Audit Pack exports 12 months of Clinical Laboratory policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.
Get the Clinical Laboratory audit pack — $349One-time purchase · not a subscription